Taiwan and Japan have reached consensus on most of the content of an investment protection agreement and will sign the accord next month, the Sankei Shimbun reported on Saturday.
The pact will allow for greater freedom of bilateral economic exchanges than the one Japan has signed with China, the business daily said
One of the features of the new pact will be provisions governing compensation for investors in the event of expropriation and other investment protection measures. It will also include most favored nations treatment, national treatment and prohibition of the export performance requirement, the paper said.
The Japan-China investment agreement that took effect in 1989 does not contain provisions for national treatment or prohibition of export performance requirements, so the Taiwan-Japan pact would pave the way for greater liberalization of economic exchanges than the Japan-China agreement, it said.
The paper also said that while China is expected to offer better terms for Taiwanese investors under the cross-strait investment pact that is being negotiated, that pact was not likely to contain a “national treatment” clause.
If the cross-strait investment accord does end up offering preferential treatment for Taiwanese investors in China, Taiwanese-Japanese joint ventures would be able to enjoy such treatment if they launch investment projects there, the Sankei Shimbun said.
Japan’s Interchange Association and Taiwan’s Association of East Asian Relations are negotiating the pact on behalf of their governments, the paper said.
An investment pact will help foster a safer and more liberal investment climate for investors. The WTO has multilateral trade regulations, but they do not stipulate cross-border investment.
The newspaper said the Japanese government has sought bilateral agreements to better protect its investors in foreign countries and has signed pacts with 15 countries and regions so far, including Egypt, China and Cambodia.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained